Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jeremy Fournier
Institution:
Arcus Biosciences (United States)
Observed institution:
Arcus Biosciences (United States)
ORCID:
0000-0003-3162-3588
Observed ORCID:
0000-0003-3162-3588
OpenAlex ID:
A5134841347
Discovery of Casdatifan, Part II: A Potent and Orally Bioavailable Inhibitor of Hypoxia Inducible Factor-2α
2026
·
Artur K. Mailyan
, Guillaume Mata
, et al.
·
Journal of Medicinal Chemistry
·
2
Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2α
2026
·
Guillaume Mata
, Artur K. Mailyan
, et al.
·
Journal of Medicinal Chemistry
·
2
Abstract 3044: PKMYT1 inhibition is synthetically lethal with CCNE1 overexpression and synergizes with standard of care chemotherapy
2026
·
Natalie Hill
, Jeremy Fournier
, et al.
·
Cancer Research
Show more works
View as search
Works count:
3
Citation count:
4
H-index:
2
I10-index:
Year
Topic
Type